Clinical Trials Sponsored by HERA Inc

Total 35618 results

Hera Biotech, Inc.

Recruiting

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

Endometriosis | Diagnosis

United States
Vera Therapeutics, Inc.

Completed

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

BK Virus Infection

United States, Canada
Sera Prognostics, Inc.

Completed

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (TREETOP)

Preterm Birth

United States
New Aera, Inc

Unknown

Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease

Interstitial Lung Disease | Chronic Obstructive Lung Disease
Vera Therapeutics, Inc.

Suspended

Atacicept in Subjects With Active Lupus Nephritis (COMPASS) (COMPASS)

Lupus Nephritis (LN)

United States, Puerto Rico, Spain
Sera Prognostics, Inc.

Completed

Proteomic Assessment of Preterm Birth (PAPR)

Preterm Birth

United States
Herba Buena, Inc

Completed

Safety and Efficacy of Dr. Tagliaferri's Menopause Formula

Hot Flashes

United States
Vera Therapeutics, Inc.

Recruiting

Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)

IgA Nephropathy | Berger Disease

United States
HERA Inc
Medical Rescue Association (MEDAK), Turkey

Not yet recruiting

A Mobile Health Intervention to Increase Uptake of Prenatal Care in Syrian Refugee Population in Turkey

Pregnancy | Prenatal Care
The Herb, Inc
ProRelix Services LLP

Completed

Study to Evaluate Efficacy and Safety of "VIRACIDE" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)

Covid19

India
Tera Group

Not yet recruiting

Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection.

COVID-19
Tera Group

Recruiting

Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.

COVID-19

United Kingdom
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Tera Group

Recruiting

Validation of TERA Bio Station T101 of COVID-19 Tested Population.

COVID-19

Turkey
Hero Scientific

Recruiting

Detection of Group A β-Hemolytic Streptococci in Oral Samples

Group A β-Hemolytic Streptococci

Israel
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (3D8)

Hepatitis C Infection

Spain
Ware Branch
Sera Prognostics, Inc.

Terminated

Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)

Preterm Birth

United States
Medical University of Vienna
Sanatorium Hera Vienna

Completed

Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients (ISCIW)

Mood Disorders | Inflammation | Anxiety Disorders | Oxidative Stress | Emotions | Psychological Stress | Affective Disorders
Bio-Thera Solutions

Not yet recruiting

An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study

Advanced Solid Tumors
Bio-Thera Solutions

Recruiting

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Endometrial Cancer

China
Bio-Thera Solutions

Not yet recruiting

A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

Carcinoma, Non-Small-Cell Lung
Bio-Thera Solutions

Recruiting

Evaluate the Safety, Tolerability of BAT6026

Dermatitis, Atopic

China
Bio-Thera Solutions

Recruiting

Clinical Study of Stage IV Psoriasis in Children With Geleli

Plaque Psoriasis

China
Bio-Thera Solutions

Not yet recruiting

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Advanced Solid Tumors
Bio-Thera Solutions

Recruiting

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

Locally Advanced/Metastatic Solid Tumours

China
Bio-Thera Solutions

Completed

Clinical Study on the Efficacy and Safety of BAT5906 Injection

Wet Age-related Macular Degeneration

China
Bio-Thera Solutions

Terminated

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

Solid Tumor

China
Bio-Thera Solutions

Completed

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

China
Bio-Thera Solutions

Terminated

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Advanced Solid Tumour

Australia
Bio-Thera Solutions

Completed

A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients

Non-Hodgkin's Lymphoma

China
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

SARS-CoV-2 Infection

China
Bio-Thera Solutions

Completed

Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects

Rheumatoid Arthritis

China
Bio-Thera Solutions

Withdrawn

A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients

COVID-19

United States
Bio-Thera Solutions

Unknown

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

HER2-Positive Solid Tumors

China
Bio-Thera Solutions

Completed

A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira

Ankylosing Spondylitis
Bio-Thera Solutions

Recruiting

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

Advanced Solid Tumor

China
Bio-Thera Solutions

Not yet recruiting

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

Healthy Men

China
Bio-Thera Solutions

Recruiting

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica Spectrum Disorders

China
Bio-Thera Solutions

Active, not recruiting

Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients

Plaque Psoriasis

China
Bio-Thera Solutions

Terminated

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

Advanced Solid Tumor

Australia
Bio-Thera Solutions

Active, not recruiting

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

Advanced Solid Tumor

China
Bio-Thera Solutions

Completed

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

Non-squamous Non-small Cell Lung Cancer

China, Mexico, South Africa, Turkey, Ukraine
Hepa Wash GmbH

Terminated

Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units (HEPATICUS-2)

Critical Illness | Liver Dysfunction

Germany
Bio-Thera Solutions

Not yet recruiting

A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Bio-Thera Solutions

Not yet recruiting

BAT1308 Combined With Platinum-Based Chemotherapy± Bevacizumab For PDL1-Positive (CPS ≥1) Cervical Cancer

Cervical Cancer

China
Bio-Thera Solutions

Recruiting

A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Optic Neuromyelitis Spectrum Disease

China
Bio-Thera Solutions

Recruiting

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Advanced or Metastatic Solid Tumors

China
Bio-Thera Solutions

Recruiting

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Neovascular (Wet) Age-related Macular Degeneration

China
Bio-Thera Solutions

Recruiting

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Advanced Solid Tumors

China
Bio-Thera Solutions

Recruiting

Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV)

Uveitis

China

3

Subscribe